What is Nexgen Compounding Pharmacy?
NexGen Pharmaceuticals operates as a specialized veterinary compounding pharmacy, catering to a broad spectrum of animal care needs. The company provides an extensive catalog of pharmaceuticals, including both branded and generic options, with a particular emphasis on sourcing hard-to-find drugs and developing custom formulations. This focus on tailored solutions and a commitment to high-quality compounds, coupled with exceptional customer service, positions NexGen as a vital partner for veterinarians seeking to address diverse medical challenges in companion, equine, non-domestic, and exotic animals. The company's pharmacists are integral to its operations, dispensing medications and offering expert guidance to ensure optimal patient outcomes.
How much funding has Nexgen Compounding Pharmacy raised?
Nexgen Compounding Pharmacy has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Nexgen Compounding Pharmacy?
The recent major strategic investment signals a pivotal growth phase for Nexgen Compounding Pharmacy. This influx of capital is likely to fuel initiatives aimed at expanding its product development pipeline, enhancing its custom formulation capabilities, and potentially broadening its market reach within the veterinary pharmaceutical industry. Strategic capital allocation may also focus on optimizing supply chain logistics for hard-to-find drugs and investing in advanced compounding technologies to maintain its competitive edge. The company's late-stage funding context suggests a focus on scaling operations and solidifying its market leadership.
See full Nexgen Compounding Pharmacy company page
